Atara Biotherapeutics Inc. (NASDAQ: ATRA) Stock Information | RedChip

Atara Biotherapeutics Inc. (NASDAQ: ATRA) Listen to this Section


$6.85
-0.8700 ( -11.30% ) 154.8K

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Market Data


Open


$6.85

Previous close


$7.72

Volume


154.8K

Market cap


$33.57M

Day range


$6.76 - $8.20

52 week range


$4.97 - $49.00

Insider Ownership Transactions

Total Amount Purchased: -820,204.00 | $ -5,618,397.40

Date Type Amount Purchased Purchaser
2024-08-14 Sale -9000.00 Touchon Pascal
2024-05-20 Sale -81506.00 Touchon Pascal
2024-05-20 Sale -25750.00 Henrich Jill
2024-05-20 Sale -28648.00 Hyllengren Eric J
2024-05-20 Sale -32401.00 Murugan Amar
2024-05-20 Sale -42899.00 Nguyen AnhCo
2024-04-02 Sale -150000.00 HEIDEN WILLIAM K
2024-04-02 Sale -150000.00 Gallagher Carol Giltner
2024-04-02 Sale -150000.00 Roncarolo Maria Grazia
2024-04-02 Sale -150000.00 Fust Matthew K

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 14, 2024
8-k 8K-related 14 Aug 12, 2024
10-q Quarterly Reports 72 Aug 12, 2024
8-k 8K-related 14 Jul 17, 2024
8-k 8K-related 14 Jun 20, 2024
8-k 8K-related 14 Jun 17, 2024
8-k 8K-related 13 Jun 11, 2024
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 20, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.